1	Transcriptional	transcriptional	_	_	_	_	_	_	_
2	control	control	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	IL-5	il-5	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	helper	helper	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	:	:	_	_	_	_	_	_	_
13	IL-5	IL-5	_	_	_	_	_	_	_
14	synthesis	synthesis	_	_	_	_	_	_	_
15	is	be	_	_	_	_	_	_	_
16	regulated	regulate	_	_	_	_	_	_	_
17	independently	independently	_	_	_	_	_	_	_
18	from	from	_	_	_	_	_	_	_
19	IL-2	il-2	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	IL-4	il-4	_	_	_	_	_	_	_
22	synthesis	synthesis	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	BACKGROUND	background	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	IL-5	IL-5	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	fundamentally	fundamentally	_	_	_	_	_	_	_
6	involved	involve	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	eosinophilic	eosinophilic	_	_	_	_	_	_	_
9	inflammation	inflammation	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	Control	Control	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	IL-5	IL-5	_	_	_	_	_	_	_
4	production	production	_	_	_	_	_	_	_
5	may	may	_	_	_	_	_	_	_
6	be	be	_	_	_	_	_	_	_
7	effective	effective	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	management	management	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	allergic	allergic	_	_	_	_	_	_	_
13	diseases	disease	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	OBJECTIVE	objective	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	We	we	_	_	_	_	_	_	_
4	aimed	aim	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	find	find	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	transcriptional	transcriptional	_	_	_	_	_	_	_
9	mechanisms	mechanism	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	regulate	regulate	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	IL-5	il-5	_	_	_	_	_	_	_
14	gene	gene	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	selectively	selectively	_	_	_	_	_	_	_
17	control	control	_	_	_	_	_	_	_
18	IL-5	il-5	_	_	_	_	_	_	_
19	synthesis	synthesis	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Allergen-specific	allergen-specific	_	_	_	_	_	_	_
4	T-cell	t-cell	_	_	_	_	_	_	_
5	clones	clone	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	T-cell	t-cell	_	_	_	_	_	_	_
8	hybridomas	hybridoma	_	_	_	_	_	_	_
9	were	be	_	_	_	_	_	_	_
10	established	establish	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	peripheral	peripheral	_	_	_	_	_	_	_
14	blood	blood	_	_	_	_	_	_	_
15	lymphocytes	lymphocyte	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	patients	patient	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	asthma	asthma	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	transcriptional	transcriptional	_	_	_	_	_	_	_
24	regulation	regulation	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	IL-5	IL-5	_	_	_	_	_	_	_
28	gene	gene	_	_	_	_	_	_	_
29	was	be	_	_	_	_	_	_	_
30	investigated	investigate	_	_	_	_	_	_	_
31	with	with	_	_	_	_	_	_	_
32	transient	transient	_	_	_	_	_	_	_
33	transfection	transfection	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	electrophoretic	electrophoretic	_	_	_	_	_	_	_
36	mobility	mobility	_	_	_	_	_	_	_
37	shift	shift	_	_	_	_	_	_	_
38	analysis	analysis	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	A	a	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	IL-5	il-5	_	_	_	_	_	_	_
6	promoter/enhancer-luciferase	promoter/enhancer-luciferase	_	_	_	_	_	_	_
7	gene	gene	_	_	_	_	_	_	_
8	construct	construct	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	pIL-5(-511)Luc	pil-5(-511)luc	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	transcribed	transcribe	_	_	_	_	_	_	_
14	on	on	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	IL-5-producing	il-5-producing	_	_	_	_	_	_	_
18	T-cell	t-cell	_	_	_	_	_	_	_
19	clones	clone	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	but	but	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	IL-5-nonproducing	il-5-nonproducing	_	_	_	_	_	_	_
24	clones.	clones.	_	_	_	_	_	_	_
25	pIL-5(-511)Luc	pil-5(-511)luc	_	_	_	_	_	_	_
26	was	be	_	_	_	_	_	_	_
27	transcribed	transcribe	_	_	_	_	_	_	_
28	by	by	_	_	_	_	_	_	_
29	T-cell	t-cell	_	_	_	_	_	_	_
30	hybridomas	hybridoma	_	_	_	_	_	_	_
31	derived	derive	_	_	_	_	_	_	_
32	from	from	_	_	_	_	_	_	_
33	fusion	fusion	_	_	_	_	_	_	_
34	between	between	_	_	_	_	_	_	_
35	IL-5-producing	il-5-producing	_	_	_	_	_	_	_
36	T-cell	t-cell	_	_	_	_	_	_	_
37	clones	clone	_	_	_	_	_	_	_
38	and	and	_	_	_	_	_	_	_
39	an	an	_	_	_	_	_	_	_
40	IL-5	il-5	_	_	_	_	_	_	_
41	gene-nonexpressing	gene-nonexpressing	_	_	_	_	_	_	_
42	T-cell	t-cell	_	_	_	_	_	_	_
43	line	line	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	but	but	_	_	_	_	_	_	_
46	not	not	_	_	_	_	_	_	_
47	by	by	_	_	_	_	_	_	_
48	hybridomas	hybridoma	_	_	_	_	_	_	_
49	derived	derive	_	_	_	_	_	_	_
50	from	from	_	_	_	_	_	_	_
51	IL-5-nonproducing	il-5-nonproducing	_	_	_	_	_	_	_
52	T-cell	t-cell	_	_	_	_	_	_	_
53	clones	clone	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	IL-5	IL-5	_	_	_	_	_	_	_
2	synthesis	synthesis	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	only	only	_	_	_	_	_	_	_
6	induced	induce	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	T-cell	t-cell	_	_	_	_	_	_	_
9	receptor	receptor	_	_	_	_	_	_	_
10	stimulation	stimulation	_	_	_	_	_	_	_
11	but	but	_	_	_	_	_	_	_
12	also	also	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	stimulation	stimulation	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Binding	binding	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NF-AT	NF-AT	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	AP-1	ap-1	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	induced	induce	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	T-cell	t-cell	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	TcR	TcR	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	stimulation	stimulation	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	although	although	_	_	_	_	_	_	_
20	there	there	_	_	_	_	_	_	_
21	was	be	_	_	_	_	_	_	_
22	no	no	_	_	_	_	_	_	_
23	significant	significant	_	_	_	_	_	_	_
24	upregulation	upregulation	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	binding	binding	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	IL-2	il-2	_	_	_	_	_	_	_
29	stimulation	stimulation	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	CONCLUSION	conclusion	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	IL-5	IL-5	_	_	_	_	_	_	_
4	synthesis	synthesis	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	human	human	_	_	_	_	_	_	_
7	helper	helper	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	regulated	regulate	_	_	_	_	_	_	_
12	at	at	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	transcriptional	transcriptional	_	_	_	_	_	_	_
15	level	level	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	unique	unique	_	_	_	_	_	_	_
3	transcriptional	transcriptional	_	_	_	_	_	_	_
4	mechanism	mechanism	_	_	_	_	_	_	_
5	distinct	distinct	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	those	those	_	_	_	_	_	_	_
8	regulating	regulate	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	IL-2	il-2	_	_	_	_	_	_	_
11	or	or	_	_	_	_	_	_	_
12	IL-4	il-4	_	_	_	_	_	_	_
13	genes	gene	_	_	_	_	_	_	_
14	seems	seem	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	control	control	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	IL-5	il-5	_	_	_	_	_	_	_
19	gene	gene	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Selective	selective	_	_	_	_	_	_	_
2	regulation	regulation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	IL-5	IL-5	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	may	may	_	_	_	_	_	_	_
8	be	be	_	_	_	_	_	_	_
9	useful	useful	_	_	_	_	_	_	_
10	for	for	_	_	_	_	_	_	_
11	treating	treat	_	_	_	_	_	_	_
12	eosinophlic	eosinophlic	_	_	_	_	_	_	_
13	inflammation	inflammation	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

